NCT01427400View on ClinicalTrials.gov

The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction

PHASE4UnknownINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2017

Conditions
Breast NeoplasmsNeoplasms by SiteNeoplasmsBreast DiseasesSkin Diseases
Interventions
DRUG

Botulinum Toxin-A

100 Units diluted in 25cc saline

DRUG

Saline

Dispensed in a 25cc syringe

Trial Locations (2)

V3V 1N1

RECRUITING

Plastic, Reconstructive and Cosmetic Surgery, Surrey

V5Z 1M9

RECRUITING

Canada, British Columbia, Vancouver

Sponsors

Collaborators (1)

Fraser Health
All Listed Sponsors
collaborator

Vancouver Coastal Health

OTHER_GOV

collaborator

Providence Health & Services

OTHER

collaborator

Fraser Health

OTHER

lead

University of British Columbia

OTHER

NCT01427400 - The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction | Biotech Hunter | Biotech Hunter